Stockreport

Assessing Dianthus Therapeutics (DNTH) Valuation After FDA Trial Shift And Renewed Analyst Optimism [Yahoo! Finance]

Dianthus Therapeutics, Inc.  (DNTH) 
PDF The FDA's decision to relax certain safety screening and testing requirements for claseprubart trials, alongside William Blair's reaffirmed positive view, has put Diant [Read more]